CONGRESOS 2017

 

Simposio-Homenaje al Prof. Juan Tamargo. "Focus en Fibrilación Auricular"
Madrid, 30 de junio de 2017

XXXVII Congreso de la Sociedad Española de Farmacología
Barcelona, 19-21 de junio de 2017

22ª Reunión Sociedad Española de Hipertensión. Liga Española para la Lucha contra la Hipertensión Arterial. SHE
Madrid, 29-31 de marzo de 2017

XII International Meeting on Atrial fibrillation and heart failure: The ugly and the nasty.
"Role of class 1 AAD revisited". Bologna (Italia), 16-17 de febrero de 2017.

6th Course of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy: Clinical Trials Programme all about Clinical Trials. “New versus old designs in clinical trials”. Bruselas, 10-11 de marzo de 2017.

7th Course of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy: Clinical Trials Programme all about Clinical Trials. “New versus old designs in clinical trials”. Roma, 26-28 de mayo de 2017.

Current status of antidotes and reversal agnets for NOACs. European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy (EuroCVP 2017). Roma, 26-28 de mayor de 2017.

37th SEF National Meeting with Guest Society: The British Pharmacological Society. "New drugs in the treatment of heart failure. Hope or hype?. Barcelona, 19 de junio de 2017.

European Society of Cardiology Congress. Juan Tamargo chairman de la Sesión Drug treatment in patients with arrhythmia y de la Sesión sobre Atrial Fibrillation. Barcelona, 28 de agosto de 2017